Evotec SE
EVOTF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesEVO
Holders of 5% or more of EVOTF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Evotec SE, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Evotec SE on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Evotec SE, newest first.
No Schedule 13D or 13G filings on Evotec SE are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Evotec SE shares.
No Form 144 notices for Evotec SE are on file.